(FBSS) |
| 0 (0%) 10-10 16:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 25.52 |
| Resistance 1: | 21.85 |
| Pivot price: | 20.81 |
| Support 1: | 20.71 |
| Support 2: | 20.00 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 8.037 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 09 Oct 2025
Spinal Cord Stimulation Devices Market Size, Share | CAGR 8.2% - Market.us
Fri, 26 Sep 2025
First Report of Transient Urinary Retention after Bilateral Lumbar ESPB in a Patient with FBSS: A Case Report - Frontiers
Wed, 11 Jun 2025
Wet Tap-Induced Spinal Cord Stimulator Trial Failure in Failed Back Surgery Syndrome: A Case Report Highlighting Intrathecal Drug Delivery for Treatment-Resistant Pain - Cureus
Thu, 30 Jan 2025
Failed Back Surgery Syndrome Market Size to Reach USD 20.9 Billion by 2035, Impelled by Rising Number of Spinal Surgeries - BioSpace
Tue, 15 Oct 2024
Hydrogen-releasing magnesium hydrogel mitigates post laminectomy epidural fibrosis through inhibition of neutrophil extracellular traps - ScienceDirect.com
Sun, 07 Apr 2024
Graded exercise with motion style acupuncture therapy for a patient with failed back surgery syndrome and major depressive disorder: a case report and literature review - Frontiers
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
